These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17297411)

  • 1. Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells.
    Jiga LP; Ehser S; Kleist C; Opelz G; Terness P
    Transplantation; 2007 Feb; 83(3):347-50. PubMed ID: 17297411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside.
    Terness P; Kleist C; Simon H; Sandra-Petrescu F; Ehser S; Chuang JJ; Mohr E; Jiga L; Greil J; Opelz G
    Hum Immunol; 2009 Jul; 70(7):506-12. PubMed ID: 19393276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of tolerogenic dendritic cells by treatment with mitomycin C: inhibition of allogeneic T-cell response is mediated by downregulation of ICAM-1, CD80, and CD86.
    Jiga LP; Bauer TM; Chuang JJ; Opelz G; Terness P
    Transplantation; 2004 Jun; 77(11):1761-4. PubMed ID: 15201679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells.
    Saiki T; Ezaki T; Ogawa M; Maeda K; Yagita H; Matsuno K
    J Leukoc Biol; 2001 May; 69(5):705-12. PubMed ID: 11358977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
    Xiang J; Gu X; Qian S; Chen Z
    Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerism in lymphoid tissues and donor-specific antibody response after injection of allogenic splenic dendritic cells from Fischer rats to Lewis recipients.
    Bocrie O; Abdelouhab K; Martin L; Guignier F; Mousson C; Rifle G
    Transplant Proc; 2006 Sep; 38(7):2349-51. PubMed ID: 16980086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats.
    Wang D; Kleist C; Ehser S; Opelz G; Terness P
    Transplantation; 2006 Dec; 82(11):1537-40. PubMed ID: 17164729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.
    Liu L; Wang F; Zheng Y; Yuan X; Wang D; Zeng W; He X; Wang C; Deng S
    Transplant Proc; 2014 May; 46(4):1169-74. PubMed ID: 24815153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD25 antibodies decrease the ability of human dendritic cells to prime allogeneic CD4 T cells.
    Mnasria K; Lagaraine C; Velge-Roussel F; Lebranchu Y; Baron C
    Transplant Proc; 2009 Mar; 41(2):695-7. PubMed ID: 19328958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
    Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrow-derived dendritic cells.
    Chen T; Xu H; Wang HQ; Zhao Y; Zhu CF; Zhang YH; Ji MJ; Hua YB; Wu WX
    Transplant Proc; 2008 Dec; 40(10):3711-3. PubMed ID: 19100471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
    Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of T-cell response and prolongation of allograft survival in a rat model by tryptophan catabolites.
    Dai X; Zhu BT
    Eur J Pharmacol; 2009 Mar; 606(1-3):225-32. PubMed ID: 19374879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
    Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.